Publication | Open Access

The Early Growth Response Gene Egr2 (Alias Krox20) Is a Novel Transcriptional Target of Transforming Growth Factor-β that Is Up-Regulated in Systemic Sclerosis and Mediates Profibrotic Responses

Transcriptional RegulationTissue DevelopmentAutoimmune DiseaseSignaling PathwayCell RegulationImmune Cell DevelopmentImmunologyTransforming Growth Factor-βSystemic SclerosisCell GrowthMedicineCell BiologyCell SignalingAlias Krox20Molecular Signaling